Primary gastric lymphoma of MALT: Considerations of pathogenesis, diagnosis and therapy

Canadian Journal of Gastroenterology

Volumn 14, Issue SUPPL. D, 2000, Pages

  Fischbach, Wolfgang ^a  

^a KLINIKUM ASCHAFFENBURG   (Germany)

Author keywords

Diagnosis; Gastric lymphoma; MALT; Mucosaassociated lymphoid tissue; Pathogenesis; Therapy

Indexed keywords

CANCER STAGING; ENDOSCOPIC ECHOGRAPHY; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOLOGY; REVIEW; STOMACH TUMOR;

ENDOSONOGRAPHY; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 0034331629     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/436854     Document Type: Article

References (50)

1. Dawson IMP, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract: report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961;49:80-9.
2. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980;46:215-22.
3. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978;42:693-707.
4. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-62.
5. Isaacson PG, Spencer J, Wright DH. Classifying primary gut lymphomas. Lancet 1988;12:1148-9.
6. Fischbach W, Kestel W, Kirchner T, Mössner J, Wilms K. Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer 1992;70:1075-80.
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
8. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: Immune response to Campylobocter pylori? J Clin Pathol 1989;42:1269-71.
9. Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campylobocter pylori. Scand J Gastroenterol 1988;23(Suppl 142):135-40.
10. Kirchner TH, Melber A, Fischbach W, Heilmann KL, Müller-Hermelink HK. Immunohistological patterns of the local immune response in Helicobacter pylori gastritis. In: Malfertheiner P, Ditschuneit H, eds. Helicobacter pylori, Gastritis and Peptic Ulcer. Berlin: Springer-Verlag, 1990:213-22.
11. Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 1992;339:745-6.
12. Wotherspoon AC, Ortiz-Hildalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
13. Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and gastric non-Hodgkin's lymphoma. J Clin Pathol 1994;47:436-9.
14. Eck M, Schmausser W, Haas R, et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997;112:1482-6.
15. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-5.
16. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994:330:1267-71.
17. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Müller-Hermelink HK. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Investigation 1994;70:572-8.
18. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
19. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobocter pylori-specific tumor-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996:178:122-7.
20. Enno A, O'Rourke J, Howlett R, et al. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis - a mouse model of He/icobocter pylori-induced gastric lymphoma. Am J Pathol 1995:147:217-22.
21. Enno A, O'Rourke J, Howlett CR, Lee A. Mouse to mouse resuscitation of low-grade MALT lymphoma induced by prolonged Helicobocter infection. A preliminary study of transplanted tumors. Gastroenterology 1996;110:A536.
22. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997;57:3944-8.
23. Stolte M, Kroher G, Meining A, Morgner A, Bayerdörffer E, Bethke B. A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients. Scand J Gastroenterol 1997;32:28-33.
24. Kolve ME, Greiner A, Müller-Hermelink HK, Wilms K, Fischbach W. Eradication of Helicobocter pylori (Hp) in gastric MALT-type lymphoma is still an experimental therapy. Gastroenterology 1997;112:A594.
25. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991;101:1159-70.
26. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 1992:102:1628-38.
27. Kolve M, Fischbach W, Greiner A, Wilms K. Differences in endoscopic and clinicopathological features of primary and secondary-gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group. Gastrointest Endosc 1999;43:307-15.
28. Fischbach W, Kolve M-E, Dragosics B, et al. Histology and stage stratified therapy offers promising results in primary gastric non-Hodgkin's lymphoma: experiences of the German-Austrian prospective multicenter trial. Gastroenterology 1998;114:A595. (Abst)
29. Musshoff K. [Clinical staging classification of non-Hodgkin's lymphoma]. Strahlentherapie 1977;153:218-21.
30. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
31. Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997;113:1087-90.
32. Fischbach W, Kolve M-E, Ohmann C. Value of endoscopic ultrasound (EUS) in staging primary gastric lymphoma: results of the German-Austrian prospective multicenter trial. Endoscopy 1995;27:534. (Abst)
33. Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a disease. Histopathology 1992;20:29-34.
34. Weber DM, Dimopoulos MA, Anandu DP, Pugh WC, Steinbach G. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994:107:1835-8.
35. Pesch S, Müller W, Borchard F, Peters U. [Low malignancy MALT lymphoma of the stomach: H. pylori eradication as a therapeutic concept] ? Z Gastroenterol 1994;32:684-7.
36. Fetscher S, Bayerdörffer E, Finke J. [78-year-old patient with chronic epigastric pain]. Internist 1995;36:1182-9.
37. Cammarota G, Montalto M, Tursi A, Vecchio FM, Fedeli G, Gasbarrini G. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet 1995;345:192.
38. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-4.
39. Morgner A, Bayerdörffer E, Neubauer A, et al. Cure of Helicobacter pylori infection in 125 patients with primary gastric low-grade MALT lymphoma. Gastroenterology 1998;114:A814. (Abst)
40. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
41. Savio A, Franzin G, Wotherspoon AC, et al. Longterm effect of anti-Helicobocter pylori therapy on gastric MALT lymphoma. Histological and molecular evaluation of 15 cases. Gut 1995;37:A246. (Abst)
42. Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. JAMA 1996:275:937-9.
43. Montalban C, Manzanal A, Boixeda D, et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT-lymphoma: Follow-up together with sequential molecular studies. Ann Oncol 1997;8(Suppl 2):37-9.
44. Tassinari D, Sartori S, Cangiotti C, et al. [Regression of primary gastric lymphoma after treatment with ranitidine]. Recenti Prog Med 1998;88:179-80.
45. Tsai MH, Hsu YH, Yang KC, et al. Low-grade gastric mucosa-associated lymphoid tissue lymphoma (MALToma): Clinical characteristics, endoscopic features, treatments and outcomes. An analysis of eight cases. Gastroenterol J Taiwan 1997;14:7-17.
46. Nobre-Leitao C, Lage P, Cravo M, et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopie ultrasonography. Am J Gastroenterol 1998;93:732-6.
47. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosaassociated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-5.
48. Fischbach W, Tacke W, Greiner A, Müller-Hermelink HK. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997:349:31-2.
49. Fischbach W, Engemann R, Stolte M. A pitfall in assessing gastric lymphoma after eradication of Helicobacter pylori. N Engl J Med 1997:336:1529-30.
50. Rackner VL, Thirlby RC, Ryan JA Jr. Role of surgery in multimodality therapy for gastrointestinal lymphoma. Am J Surg 1991;161:570-5.